Oncology News Central Peer-Spectives
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
Episodes (100)
Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Oncology News Central Peer-Spectives
Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Oncology News Central Peer-Spectives
“Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Trea...
Oncology News Central Peer-Spectives
“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm...
Oncology News Central Peer-Spectives
As Terminal Patients Live Longer, How Can Oncologists Help Them Cope With Uncert...
Oncology News Central Peer-Spectives
Should Patients With Cancer Receive mRNA Vaccines Alongside Immunotherapy?
Oncology News Central Peer-Spectives
Big News From ESMO 2025 Changes Practice in Bladder Cancer
Oncology News Central Peer-Spectives
Big Changes in AML Care as Targeted Therapy Options Expand
Oncology News Central Peer-Spectives
Artificial Sweetener May Impair Cancer Immunotherapy, Raising Broader Questions
Oncology News Central Peer-Spectives
“Massive Advance” Changes the Chessboard in EGFR-Mutated Metastatic NSCLC
Oncology News Central Peer-Spectives
Are Oral SERDs About to Transform Breast Cancer Care?
Oncology News Central Peer-Spectives
Game-Changers and Paradigm Shifts: ASCO 2025 Data Shake Up Breast Cancer Care
Oncology News Central Peer-Spectives
Practice-Changing Data in Colorectal Cancer Lead to Broader Questions in Oncolog...
Oncology News Central Peer-Spectives
Oncologist Faculty Burnout Caused by “Unrealistic” Expectations, Says ASCO CEO
Oncology News Central Peer-Spectives
After Years of Inactivity, “Dizzying” Changes Hit Bladder Cancer Care
Oncology News Central Peer-Spectives
Practice Changing or “Practice Confounding”? Pivotal Breast Cancer Data Raise Bi...
Oncology News Central Peer-Spectives
NCCN CEO Discusses Guideline Updates, Other Key Initiatives
Oncology News Central Peer-Spectives
Former National Cancer Institute Director Discusses the Future of Cancer Care
Oncology News Central Peer-Spectives
Game-Changing Blood Cancer News at ASCO 2025: Rusfertide Shows Strong Benefit in...
Oncology News Central Peer-Spectives
Getting Americans to Support Cancer Research May Take a New Message, Oncology Le...
Oncology News Central Peer-Spectives
“Important Milestone”: Perioperative Durvalumab Improves Event-Free Survival in...
Oncology News Central Peer-Spectives
What Does the Biggest News in Breast Cancer From ASCO 2025 Mean for Practice Rig...
Oncology News Central Peer-Spectives
Practice-Changing “Inflection Point” Coming in ESR1-Positive Breast Cancer Care?
Oncology News Central Peer-Spectives
When ESR1 Mutations Arise in Breast Cancer Patients With PIK3CA Mutations: What...
Oncology News Central Peer-Spectives
How “Remarkable Change” in EGFR-Mutated NSCLC Care Is Making a Difference for Pa...
Oncology News Central Peer-Spectives
Oncologists Urged to Discuss Fertility With Patients, as ASCO Updates Guidelines
Oncology News Central Peer-Spectives
“Second-Line ER-Positive Breast Cancer Has Just Become Very Complicated”
Oncology News Central Peer-Spectives
Will Generational Divide Among Oncologists Affect How AI Changes Cancer Care?
Oncology News Central Peer-Spectives
“Time to Move On”: How Targeted Therapies Are Transforming AML Care
Oncology News Central Peer-Spectives
ASCO President Speaks Out on “Huge Problem” of Oncologist Burnout
Oncology News Central Peer-Spectives
Oncologists Overtreat Patients at End of Life
Oncology News Central Peer-Spectives
FDA Approvals Change Practice for Metastatic Breast Cancer With PIK3CA Mutations
Oncology News Central Peer-Spectives
To Help Oncologists’ Burnout, Should Primary Care Take on More Burden?
Oncology News Central Peer-Spectives
Choosing Between an “Old Friend” and New Ones in EGFR-Mutated Metastatic NSCLC
Oncology News Central Peer-Spectives
Privatization of Cancer Clinical Research Raises Concerns for Practice
Oncology News Central Peer-Spectives
What 3 Big Trials Mean for Breast Cancer Practice
Oncology News Central Peer-Spectives
“Confusing for All of Us”: Questions Arise Over ADCs, HER2 in Metastatic Breast...
Oncology News Central Peer-Spectives
”Where Do We Go From Here?” Targeted Therapies Lead to Challenging Choices in Br...
Oncology News Central Peer-Spectives
After Practice Change in Unresectable Stage III NSCLC, Questions Remain
Oncology News Central Peer-Spectives
What ”Incredibly Dramatic” Data on Osimertinib in NSCLC Mean for Practice
Oncology News Central Peer-Spectives
“Smart Bombs” Upend Breast Cancer Care: What Oncologists May Not Know About Anti...
Oncology News Central Peer-Spectives
Oncology Must Do More for Long-Term Cancer Survivors, Expert Says
Oncology News Central Peer-Spectives
“A Good, Peaceful Death” From Cancer: Oncologists Must Be Part of “National Dial...
Oncology News Central Peer-Spectives
FDA Approvals in Relapsed/Refractory CLL Set up ”Difficult Choice”
Oncology News Central Peer-Spectives
Oncologists Struggling With Cancer Deaths Among Millennial Patients
Oncology News Central Peer-Spectives
Top Lung Cancer Data From ASCO 2024 Should Change Practice “Immediately,” Expert...
Oncology News Central Peer-Spectives
What Were the Biggest Data at ASCO 2024 in Kidney Cancer?
Oncology News Central Peer-Spectives
What New “Elephant in the Room” Means for Bladder Cancer Care
Oncology News Central Peer-Spectives
Immunotherapy in “Hardest Stage” of NSCLC: Putting Recent Advances Into Practice
Oncology News Central Peer-Spectives
”We’re Past the Inflection Point,” as ”Massive Change” Hits Breast Cancer Care
Oncology News Central Peer-Spectives